Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel (albumin-bound) + oxaliplatin + S-1 as preoperative treatment for gastric cancer
ChiCTR2000032702Phase 4Recruiting
- Sponsor
- Gansu Provincial People's Hospital
- Start
- May 2020
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paclitaxel, oxaliplatin and tegafur in gastric cancer (GC) and esophagogastric junction cancer, sponsored by Gansu Provincial People's Hospital. Primary endpoints: pathological complete remission, objective response rate and 1 more. Started May 2020; status: recruiting.
02
Drugs
paclitaxeloxaliplatintegafur
03
Conditions
gastric cancer (GC)esophagogastric junction cancer
Beyond the preview
Go deeper on ChiCTR2000032702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032702.